6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[4,3-b]pyridine
95%
- Product Code: 120615
CAS:
1416713-01-3
| Molecular Weight: | 282.14 g./mol | Molecular Formula: | C₁₁H₁₂BrN₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22689898 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of more complex molecules. Its structure is particularly valuable in the creation of potential therapeutic agents, especially in the field of oncology and neurology. Researchers leverage its pyrazolopyridine core to design and develop inhibitors targeting specific enzymes or receptors involved in disease pathways. Additionally, it is employed in medicinal chemistry for the exploration of novel drug candidates, owing to its ability to interact with biological targets effectively. Its incorporation into drug discovery programs aids in optimizing pharmacokinetic properties and enhancing the efficacy of lead compounds.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿2,583.00 |
+
-
|
| 0.250 | 10-20 days | ฿5,166.00 |
+
-
|
6-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[4,3-b]pyridine
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of more complex molecules. Its structure is particularly valuable in the creation of potential therapeutic agents, especially in the field of oncology and neurology. Researchers leverage its pyrazolopyridine core to design and develop inhibitors targeting specific enzymes or receptors involved in disease pathways. Additionally, it is employed in medicinal chemistry for the exploration of novel drug candidates, owing to its ability to interact with biological targets effectively. Its incorporation into drug discovery programs aids in optimizing pharmacokinetic properties and enhancing the efficacy of lead compounds.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :